TrialOncoimmunology2026

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Charles X Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.